Allergan and Molecular Partners Enter into Exclusive Alliance
Global partnership will develop novel products for eye diseases
23-Aug-2012 -
Allergan, Inc. and Molecular Partners AG announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin® products for the treatment of serious ophthalmic diseases.Molecular ...
age-related macular degeneration
Allergan
ophthalmology